As healthcare systems worldwide shift toward personalized treatment, biopharmaceuticals are gaining momentum for their ability to target disease mechanisms at the molecular level. The rapid ...

Australia’s growing reliance on high-cost biologics for inflammatory skin diseases has placed significant pressure on its ...

Quarter ResultsFormycon reports strong operational performance and financial results for first quarter of 2025 12.05.2025 / 06:30 CET/CESTThe issuer is solely responsible for the content of this ...

Research conducted at the Suez Canal University endocrinology outpatient clinic in Ismailia City, Egypt and released in 2024, ...

Manufacturing Digital's top 10 biggest pharmaceutical manufacturers delivering innovative healthcare and improved patient ...

Barclays analyst Emily Field maintained a Buy rating on Sandoz Group Ltd (SDZXF – Research Report) today and set a price target of CHF46.50. The company’s shares closed last M ...

Campbell covers the Healthcare sector, focusing on stocks such as Chemical Works of Gedeon Richter, Sandoz Group Ltd, and Pharming Group. According to TipRanks, Campbell has an average return of 1.1% ...

Good morning, ladies and gentlemen, and welcome to the Sandoz call today. I will now pass on to Craig Marks, Head of Investor Relations, for his opening remarks. Thank you. Welcome to the Sandoz Q1 ...

To find the month’s 10 best-performing income-focused stocks, we screened the Morningstar Dividend Leaders Index, which tracks the performance of the 100 highest-yielding stocks from a broad ...

The stock currently trades at $43.49, showing remarkable resilience with a 10.25% gain over the past week. According to InvestingPro data, Sandoz maintains its position as a prominent player in the ...